Cargando…
Nasopharyngeal carcinoma: molecular biomarker discovery and progress
Nasopharyngeal carcinoma (NPC) is a rare malignancy in most part of the world and it is one of the most confusing, commonly misdiagnosed and poorly understood diseases. The cancer is an Epstein-Barr virus-associated malignancy with a remarkable racial and geographical distribution. It is highly prev...
Autor principal: | Cho, William Chi-shing |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1774581/ https://www.ncbi.nlm.nih.gov/pubmed/17199893 http://dx.doi.org/10.1186/1476-4598-6-1 |
Ejemplares similares
-
Nasopharyngeal Carcinoma Signaling Pathway: An Update on Molecular Biomarkers
por: Tulalamba, Warut, et al.
Publicado: (2012) -
Current Status and Future Perspectives about Molecular Biomarkers of Nasopharyngeal Carcinoma
por: Siak, Pui Yan, et al.
Publicado: (2021) -
Feature Reviews of the Molecular Mechanisms of Nasopharyngeal Carcinoma
por: Liao, Li-Jen, et al.
Publicado: (2023) -
Biomarkers for enhancing the radiosensitivity of nasopharyngeal carcinoma
por: Chen, Wei, et al.
Publicado: (2015) -
The Progress on Genetic Analysis of Nasopharyngeal Carcinoma
por: Zhou, Xiaofeng, et al.
Publicado: (2007)